Skip to main content

Health Catalyst, Inc.

corporate_fare Company Profile

Health Catalyst, Inc.

HCAT·NASDAQ·Technology·CIK 0001636422

Health Catalyst is a leading provider of data and analytics technology and services for healthcare organizations. The company's Solution includes a cloud-based data and analytics platform, software applications, and specialized expertise. Healthcare providers, who are the primary clients, utilize this Solution to manage their data, gain analytical insights for organizational operations, and achieve measurable improvements in clinical, financial, and operational areas. The company's mission is to be a catalyst for massive, measurable, data-informed healthcare improvement. This is achieved through several key elements: a Data and Analytics Platform that integrates data in a flexible, open, scalable, and modular way to power insights; Applications that deliver analytics insights for measurable improvement and automate processes for efficiency; and Expertise, which enables data-informed improvement through specialized knowledge and managed services. These components collectively drive measurable improvements, fostering client trust and engagement. The company also prioritizes team member engagement, which is foundational to its operations and client success. As clients realize improvements, their trust in Health Catalyst grows, leading to increased engagement, renewals, expansions, and referrals to other potential clients.

Health Catalyst, Inc. (NASDAQ:HCAT) is a publicly traded company in the Technology sector. Wiseek monitors HCAT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Activist Investor Whetstone Capital Proposes Major Governance Reforms at Health Catalyst
  • Health Catalyst Reports Preliminary 2025 Results Exceeding Revenue and Client Targets, Outlines 2026 Strategic Focus

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$311.14M
Net Income
-$177.97M
Diluted EPS
-$2.55
Op. Cash Flow
$731K
Free Cash Flow
-$237K
Operating Income
-$160.85M
Cash & Equivalents
$50.81M
Total Debt
$153.25M
Debt / Equity
0.62×
Net Margin
-57.2%
Shares Outstanding
72.03M sh
Source: 10-K · filed 2026-04-30 · accession 0001636422-26-000055
$2.08
52-week range · as of 2026-07-17 $0.9551 – $4.12
Market cap
$153.7M
Volume
423.8K (0.3× avg)
3-mo avg 1.3M
Live data · 2026-07-27 05:43 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed HCAT - Filings & News (Page 2)

HCAT
Jan 21, 2026, 8:39 AM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $2.21
Real-time Price: $2.08 info
Change: -$0.130 (-6%) info
Market Cap: $153.7M info
HCAT
Jan 12, 2026, 4:26 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.46
Real-time Price: $2.08 info
Change: -$0.380 (-15%) info
Market Cap: $153.7M info